Delray Medical Center Is First Hospital in Region Offering INSIGHTEC™

New Incisionless RX Option for Parkinson’s & Essential Tremor Patients

Delray Medical Center is the first hospital in the region to offer a new scalpel-free treatment for essential tremor and medication-refractory tremor-dominant Parkinson’s disease.

MR-guided focused ultrasound by INSIGHTEC™, uses sound wave energy to treat brain tissue at the source of the tremor.  No surgical incision or anesthesia is necessary, and patients may experience immediate and significant reduction in their hand tremors, giving them a chance to get back to their daily activities.

“This Technology Is A Game Changer In Our Community And For Those Seeking The Very Latest In Cutting Edge Technology For Neurologic Care Of Parkinson’s Disease,” Said Dr. Lloyd Zucker, Chief Of Neurosurgery At Delray Medical Center.
“This technology is a game-changer in our community and for those seeking the very latest in cutting edge technology for neurologic care of Parkinson’s disease,” said Dr. Lloyd Zucker, chief of neurosurgery at Delray Medical Center. “The future is bright for those who may be stricken with this neurological disease, as we can care for these patients with this new innovative solution to treat tremors.”

MR-guided focused ultrasound combines two technologies, magnetic resonance imaging (MRI), which pinpoints the exact location in the brain responsible for the tremor, and ultrasound, which precisely delivers over 1,000 highly focused beams of acoustic energy at that exact location without damaging any surrounding brain tissue.

Some of the benefits to this technology include:

  • No surgical incisions resulting in reduced risk of infection.
  • Quicker recovery time with no surgical incision, allowing a return to daily activities within days.
  • Performed as an outpatient procedure – most patients go home within 23 hours.
  • Immediate and significant reduction in hand tremors.
  • Treatment has minimum side effects.

“Delray Medical Center is proud to be the first hospital in the region to offer this new technology to the community who are in need of top notch neurologic care,” said Dr. Arif Dalvi, medical director of the movement disorder center for Delray Medical Center.  “We continue to bring breakthrough treatments to our hospital so patients can find quality care close to home.”

Delray Medical Center has the advanced technology and services to help with any of your neurological issues.  As a member of the Advanced Neuroscience Network, an integrated delivery system of medical professionals and hospitals focused on offering a full continuum of neurological care throughout South Florida, we focus on everything from prevention and diagnosis to treatment and rehabilitation.  For more information about our services go to our website at www.delraymedicalctr.com or call 561-498-4440.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.